1. Home
  2. CMT vs GNLX Comparison

CMT vs GNLX Comparison

Compare CMT & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Core Molding Technologies Inc

CMT

Core Molding Technologies Inc

HOLD

Current Price

$21.28

Market Cap

180.0M

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$4.37

Market Cap

202.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMT
GNLX
Founded
1996
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
180.0M
202.4M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
CMT
GNLX
Price
$21.28
$4.37
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$19.75
AVG Volume (30 Days)
25.7K
140.8K
Earning Date
11-04-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.93
N/A
Revenue
$261,619,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.66
N/A
P/E Ratio
$22.99
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.25
$1.99
52 Week High
$22.29
$8.54

Technical Indicators

Market Signals
Indicator
CMT
GNLX
Relative Strength Index (RSI) 65.36 40.57
Support Level $19.78 $4.20
Resistance Level $21.43 $4.37
Average True Range (ATR) 0.85 0.29
MACD 0.09 0.05
Stochastic Oscillator 100.00 32.35

Price Performance

Historical Comparison
CMT
GNLX

About CMT Core Molding Technologies Inc

Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam, and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Share on Social Networks: